The Board of Globalspace Technologies at its meeting held on 08 March 2024 has approved the acquisition of 51% stake of Innopharm Healthcare (CIN: U74999MH2015PTC267088) by executing a share swap transaction. Powered by Capital Market - Live News

Net profit of Globalspace Technologies declined 37.50% to Rs 0.15 crore in the quarter ended December 2023 as against Rs 0.24 crore during the previous quarter ended December 2022. Sales rose 11.10% to Rs 7.81 crore in the quarter ended December 2023 as against Rs 7.03 crore during the previous quarter ended December 2022. ParticularsQuarter Ended�Dec. 2023Dec. 2022% Var. Sales7.817.03 11 OPM %17.0324.04 - PBDT1.001.11 -10 PBT0.190.19 0 NP0.150.24 -38 Powered by Capital Market - Live News

Globalspace Technologies will hold a meeting of the Board of Directors of the Company on 12 February 2024.Powered by Capital Market - Live News

Net profit of Globalspace Technologies rose 66.67% to Rs 0.15 crore in the quarter ended September 2023 as against Rs 0.09 crore during the previous quarter ended September 2022. Sales rose 31.84% to Rs 7.04 crore in the quarter ended September 2023 as against Rs 5.34 crore during the previous quarter ended September 2022. ParticularsQuarter Ended�Sep. 2023Sep. 2022% Var. Sales7.045.34 32 OPM %23.0127.72 - PBDT0.990.99 0 PBT0.220.13 69 NP0.150.09 67 Powered by Capital Market - Live News

Globalspace Technologies will hold a meeting of the Board of Directors of the Company on 3 November 2023.Powered by Capital Market - Live News